GRANTS

348 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Pilot/Feasibility Project Awards

Sponsor: UAB’s Nathan Shock Center of Excellence in the Basic Biology of Aging

Award: Generally less than $10,000, although larger budgets are considered if fully justified. Awards are for 1 year. Applications from institutions outside of the UAB are particularly encouraged. Additional funds are available for studies utilizing Shock Center Cores and UAB’s Microbiome Core. For those interested in pursuing these grants, contact Casey Morrow (caseym@uab.edu).

Due Date: July 1 and October 1, 2018

Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (RFA-AG-

Sponsor: National Institute on Aging, National Institute of Neurological Disorders and Stroke

Award: NIH intends to commit $1.8 million in FY 2019 to fund 12-15 awards for this FOA and its companion. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: July 3, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (RFA-AG-

Sponsor: National Institute on Aging, National Institute of Neurological Disorders and Stroke

Award: NIH intends to commit $1.8 million in FY 2019 to fund 12-15 awards for this FOA and its companion. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: July 3, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

2018-2019 Oklahoma Pilot Project Awards

Sponsor: Nathan Shock Center

Award: The awards are for one year and are generally between $10,000 and $20,000 depending on the specific needs of the applicant.

Due Date: June 1, 2018

In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimate of three to five awards, corresponding to a total of $1.5 million, for fiscal year 2018. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) (RFA-NS-18-030)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $15 million to fund 20 awards.

Due Date: July 3, 2018; November 6, 2018; July 3, 2019; November 6, 2019; July 1, 2020; November 10, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: June 19, 2018, October 17, 2018, February 20, 2019, June 19, 2019, October 17, 2019, February 19, 2020, June 17, 2020, October 20, 2020 and February 17, 2021 apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: June 19, 2018, October 17, 2018, February 20, 2019, June 19, 2019, October 17, 2019, February 19, 2020, June 17, 2020, October 20, 2020 and February 17, 2021 apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinic

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: ): June 19, 2018, October 17, 2018, February 20, 2019, June 19, 2019, October 17, 2019, February 19, 2020, June 17, 2020, October 20, 2020 and February 17, 2021 apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

ADDF-Harrington Scholar Program

Sponsor: Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Award

Award: Up to $300,000 per year for two years.

Due Date: May 25, 2018

Current Filters

No filters selected

Filter By